Search Ontology:
ChEBI
orlistat
- Term ID
- CHEBI:94686
- Synonyms
-
- (-)-tetrahydrolipostatin
- (2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate
- (2S)-2-formamido-4-methylpentanoic acid [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester
- Alli
- N-formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester
- orlipastat
- orlistat
- orlistatum
- Ro-18-0647
- Xenical
- Definition
- A carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug.
- References
-
- CAS:96829-58-2
- Drug_Central:1996
- KEGG:D04028
- LINCS:LSM-5724
- PMID:27793869
- PMID:28097013
- PMID:28191026
- PMID:28260907
- PMID:28387458
- PMID:28559211
- PMID:28588183
- PMID:28624425
- Patent:EP129748
- Patent:US4598089
- Reaxys:3658031
- Wikipedia:Orlistat
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from orlistat
Phenotype where environments contain orlistat
Phenotype modified by environments containing orlistat
Human Disease Model